SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced ...

Flagship Pioneering’s Lila Sciences has landed a substantial $235 million series A as it looks to exceed the current limits ...

CRISPR-GPT, a large language model developed at Stanford Medicine, is accelerating gene-editing processes and increasing accessibility to CRISPR.

Still, for the most part, the CRISPR revolution doesn’t really look like a revolution. The labs are a little nicer, there’s more money involved and there’s probably a little more fervor. The stakes ...

Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of Foot-and-Mouth ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently, there is no effective treatment or ...

CRISPR’s promise of curing diseases hit a setback when researchers discovered that AZD7648, a molecule designed to improve precision, also caused catastrophic hidden damage to DNA. Instead of perfect ...